Response to steroid therapy in autism secondary to autoimmune lymphoproliferative syndrome
- 1 May 2000
- journal article
- case report
- Published by Elsevier in The Journal of Pediatrics
- Vol. 136 (5) , 682-687
- https://doi.org/10.1067/mpd.2000.105355
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Characterization and comparison of autistic subgroups: 10 years' experience with autistic childrenDevelopmental Medicine and Child Neurology, 1999
- Correction of Fas (CD95) deficiency by haploidentical bone marrow transplantationEuropean Journal of Immunology, 1997
- Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?Journal of Clinical Investigation, 1997
- Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease.Journal of Clinical Investigation, 1996
- Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover.The Journal of cell biology, 1996
- Mutations in Fas Associated with Human Lymphoproliferative Syndrome and AutoimmunityScience, 1995
- Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndromeCell, 1995
- Lymphocyte Function in Autism and Rett SyndromeNeuropsychobiology, 1994
- A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease.Journal of Clinical Investigation, 1992
- Effect of Early Corticosteroid Therapy for Landau‐Kleffner SyndromeDevelopmental Medicine and Child Neurology, 1991